Literature DB >> 7793479

Papillary Hürthle cell carcinoma with lymphocytic stroma. "Warthin-like tumor" of the thyroid.

R L Apel1, S L Asa, V A LiVolsi.   

Abstract

We report 13 cases of a peculiar thyroid tumor of follicular epithelial differentiation with distinctly papillary architecture, oxyphilic cytology, and lymphocytic infiltrates in papillary stalks. The majority of these tumors arose in glands with chronic lymphocytic thyroiditis. The combination of oxyphilic cells and lymphocytic stroma gives these tumors a startling resemblance to papillary cystadenoma lymphomatosum, or "Warthin's tumor" of the salivary gland. Twelve tumors occurred in women (age range: 26-66 years, mean 44 years). Two tumors were in the isthmus, six in the right lobe, and four in the left lobe. The only man, 34 years old, had multiple bilateral tumor nodules. The lesions ranged from 0.3 cm to 3.5 cm in maximum dimension. The largest lesion, in a 58-year-old woman, infiltrated skeletal muscle. Three other patients had lymph node metastases, while the nine remaining tumors were confined to the thyroid. Follow-up in these cases suggests that although the histological appearance of these neoplasms is unusual, they behave as typical papillary carcinomas. The striking lymphocytic infiltration and oxyphilic metaplasia in these tumors as well as the association with chronic lymphocytic thyroiditis suggest that as yet undefined immunological mechanisms may play a role in the pathogenesis of this disorder.

Entities:  

Mesh:

Year:  1995        PMID: 7793479

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  24 in total

1.  Warthin-like tumor of the thyroid a case report.

Authors:  E Sarkady; Z Sápi; V Tóth; S Kiss
Journal:  Pathol Oncol Res       Date:  1999       Impact factor: 3.201

Review 2.  Unusual types of thyroid cancer.

Authors:  K B Ain
Journal:  Rev Endocr Metab Disord       Date:  2000-04       Impact factor: 6.514

Review 3.  Papillary carcinoma of thyroid: A 30-yr clinicopathological review of the histological variants.

Authors:  Alfred King-Yin Lam; Chung-Yau Lo; Karen Siu-Ling Lam
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

4.  The cytoplasmic expression of MUC1 in papillary thyroid carcinoma of different histological variants and its correlation with cyclin D1 overexpression.

Authors:  Alexander Abrosimov; Vladimir Saenko; Serik Meirmanov; Masahiro Nakashima; Tatiana Rogounovitch; Olesya Shkurko; Eugeny Lushnikov; Norisato Mitsutake; Hiroyuki Namba; Shunichi Yamashita
Journal:  Endocr Pathol       Date:  2007       Impact factor: 3.943

Review 5.  Papillary carcinoma tall cell variant (TCV): a review.

Authors:  Virginia A LiVolsi
Journal:  Endocr Pathol       Date:  2010-03       Impact factor: 3.943

6.  Warthin tumor-like variant of papillary thyroid carcinoma: a case with dedifferentiation (anaplastic changes) and aggressive biological behavior.

Authors:  King Yin Lam; Chung Yau Lo; William I Wei
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

7.  Fine Needle Aspiration Cytology of Warthin-like Papillary Thyroid Carcinoma: A Brief Case Report.

Authors:  Yosep Chong; Sungwook Suh; Tae-Jung Kim; Eun Jung Lee
Journal:  Korean J Pathol       Date:  2014-04-28

8.  Solid papillary thyroid carcinoma with Hashimoto's thyroiditis: description of a further case with challenging cytological features.

Authors:  Franco Fulciniti; Jessica Barizzi; Pierpaolo Trimboli; Luca Giovanella
Journal:  BMJ Case Rep       Date:  2019-01-17

9.  Warthin tumor-like papillary thyroid carcinoma with a minor dedifferentiated component: report of a case with clinicopathologic considerations.

Authors:  Paolo Amico; Salvatore Lanzafame; Giovanni Li Destri; Paolo Greco; Rosario Caltabiano; Giada Maria Vecchio; Gaetano Magro
Journal:  Case Rep Med       Date:  2010-06-07

10.  Hurthle cell carcinoma arising from thyroid papillary carcinoma.

Authors:  L Jonathan Zwi; Virginia A LiVolsi
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.